RGT 2.90% 35.5¢ argent biopharma limited

Ann: Investor Presentation - CimetrA, page-2

  1. 14,010 Posts.
    lightbulb Created with Sketch. 2383
    "Wide use in community and hospitals"

    I think that might be another MXC marketing furphy. They do come out with them from time to time. Unless there was a major order to hospitals that I missed, then only the orders that have come in for community use would have any significance. I have strong suspicions that most hospitals would not be authorised to use CimetrA on patients.

    Once again, a nice glossy promotional piece - something that MXC does well.

    CimetrA acceptance is growing BUT the promotional document paint too rosy a picture of current realities. As CimetrA is becoming the main product for MXC, then I suppose there is some justification of prying to push the product.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.